` Comparison: ADK vs 2413 - Alpha Spread

ADK
vs
2413

Over the past 12 months, ADK has outperformed M3 Inc, delivering a return of -2% compared to the M3 Inc's 9% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ADK
2413
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ADK Intrinsic Value
LOCKED
Unlock
M3 Inc Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Diagnos Inc
XTSX:ADK
0.275 CAD
M3 Inc
TSE:2413
1 588 JPY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ADK, 2413

ADK
2413
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Diagnos Inc
Revenue
M3 Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ADK, 2413

ADK
2413
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Diagnos Inc
XTSX:ADK
M3 Inc
TSE:2413
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ADK
-2 089.6%
M3 Inc
50.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Diagnos Inc
M3 Inc

Operating Margin

ADK
-6 479.6%
M3 Inc
21.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Diagnos Inc
M3 Inc

Net Margin

ADK
-6 903.2%
M3 Inc
14.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Diagnos Inc
M3 Inc

FCF Margin

ADK
-5 607.2%
M3 Inc
15.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Diagnos Inc
M3 Inc

ROE

ADK
-924.3%
M3 Inc
13%
LTM 3Y Avg 5Y Avg 10Y Avg
Diagnos Inc
M3 Inc

ROA

ADK
-132.6%
M3 Inc
8.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Diagnos Inc
M3 Inc

ROIC

ADK
-2 662.1%
M3 Inc
13.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Diagnos Inc
M3 Inc

ROCE

ADK
-487.6%
M3 Inc
14.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Diagnos Inc
M3 Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ADK, 2413

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ADK, 2413

Performance Gap Between ADK and 2413
LOCKED
Unlock

Performance By Year
ADK, 2413

Loading
ADK
2413
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ADK to other stocks
0R00
Cerner Corp
C
More expensive
vs ADK
VEEV
Veeva Systems Inc
Cheaper
vs ADK
PME
Pro Medicus Ltd
Cheaper
vs ADK
WAY
Waystar Holding Corp
W
Cheaper
vs ADK
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett